Literature DB >> 25712966

Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy.

Susanne von Stockenstrom1, Lina Odevall2, Eunok Lee3, Elizabeth Sinclair4, Peter Bacchetti5, Maudi Killian4, Lorrie Epling4, Wei Shao6, Rebecca Hoh4, Terence Ho4, Nuno R Faria7, Philippe Lemey7, Jan Albert1, Peter Hunt4, Lisa Loeb4, Christopher Pilcher4, Lauren Poole4, Hiroyu Hatano4, Ma Somsouk4, Daniel Douek8, Eli Boritz8, Steven G Deeks4, Frederick M Hecht4, Sarah Palmer9.   

Abstract

BACKGROUND: The stability of the human immunodeficiency virus type 1 (HIV-1) reservoir and the contribution of cellular proliferation to the maintenance of the reservoir during treatment are uncertain. Therefore, we conducted a longitudinal analysis of HIV-1 in T-cell subsets in different tissue compartments from subjects receiving effective antiretroviral therapy (ART).
METHODS: Using single-proviral sequencing, we isolated intracellular HIV-1 genomes derived from defined subsets of CD4(+) T cells from peripheral blood, gut-associated lymphoid tissue and lymph node tissue specimens from 8 subjects with virologic suppression during long-term ART at 2 time points (time points 1 and 2) separated by 7-9 months.
RESULTS: DNA integrant frequencies were stable over time (<4-fold difference) and highest in memory T cells. Phylogenetic analyses showed that subjects treated during chronic infection contained viral populations with up to 73% identical sequence expansions, only 3 of which were observed in specimens obtained before therapy. At time points 1 and 2, such clonally expanded populations were found predominantly in effector memory T cells from peripheral blood and lymph node tissue specimens.
CONCLUSIONS: Memory T cells maintained a relatively constant HIV-1 DNA integrant pool that was genetically stable during long-term effective ART. These integrants appear to be maintained by cellular proliferation and longevity of infected cells, rather than by ongoing viral replication.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV-1 persistence; HIV-1 reservoir; memory T cells

Mesh:

Substances:

Year:  2015        PMID: 25712966      PMCID: PMC4539896          DOI: 10.1093/infdis/jiv092

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase.

Authors:  Mary Kearney; Sarah Palmer; Frank Maldarelli; Wei Shao; Michael A Polis; JoAnn Mican; Diane Rock-Kress; Joseph B Margolick; John M Coffin; John W Mellors
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

2.  Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.

Authors:  H F Günthard; D V Havlir; S Fiscus; Z Q Zhang; J Eron; J Mellors; R Gulick; S D Frost; A J Brown; W Schleif; F Valentine; L Jonas; A Meibohm; C C Ignacio; R Isaacs; R Gamagami; E Emini; A Haase; D D Richman; J K Wong
Journal:  J Infect Dis       Date:  2001-04-10       Impact factor: 5.226

3.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

4.  Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Authors:  Sarah Palmer; Mary Kearney; Frank Maldarelli; Elias K Halvas; Christian J Bixby; Holly Bazmi; Diane Rock; Judith Falloon; Richard T Davey; Robin L Dewar; Julia A Metcalf; Scott Hammer; John W Mellors; John M Coffin
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

5.  Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.

Authors:  Steven A Yukl; Amandeep K Shergill; Kenneth McQuaid; Sara Gianella; Harry Lampiris; C Bradley Hare; Mark Pandori; Elizabeth Sinclair; Huldrych F Günthard; Marek Fischer; Joseph K Wong; Diane V Havlir
Journal:  AIDS       Date:  2010-10-23       Impact factor: 4.177

6.  Rapid turnover of effector-memory CD4(+) T cells in healthy humans.

Authors:  Derek C Macallan; Diana Wallace; Yan Zhang; Catherine De Lara; Andrew T Worth; Hala Ghattas; George E Griffin; Peter C L Beverley; David F Tough
Journal:  J Exp Med       Date:  2004-07-12       Impact factor: 14.307

7.  HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection.

Authors:  Thor A Wagner; Sherry McLaughlin; Kavita Garg; Charles Y K Cheung; Brendan B Larsen; Sheila Styrchak; Hannah C Huang; Paul T Edlefsen; James I Mullins; Lisa M Frenkel
Journal:  Science       Date:  2014-07-10       Impact factor: 47.728

8.  Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.

Authors:  M Kearney; F Maldarelli; W Shao; J B Margolick; E S Daar; J W Mellors; V Rao; J M Coffin; S Palmer
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

9.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

10.  Interleukin 7 regulates the survival and generation of memory CD4 cells.

Authors:  Robyn M Kondrack; Judith Harbertson; Joyce T Tan; Meghan E McBreen; Charles D Surh; Linda M Bradley
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  86 in total

Review 1.  HIV-specific CD8⁺ T cells and HIV eradication.

Authors:  R Brad Jones; Bruce D Walker
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

2.  Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.

Authors:  Hiromi Imamichi; Robin L Dewar; Joseph W Adelsberger; Catherine A Rehm; Una O'Doherty; Ellen E Paxinos; Anthony S Fauci; H Clifford Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

Review 3.  Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.

Authors:  Stella J Berendam; Ashley N Nelson; Ria Goswami; Deborah Persaud; Nancy L Haigwood; Ann Chahroudi; Genevieve G Fouda; Sallie R Permar
Journal:  Curr HIV/AIDS Rep       Date:  2020-06       Impact factor: 5.071

Review 4.  The multifaceted nature of HIV latency.

Authors:  Caroline Dufour; Pierre Gantner; Rémi Fromentin; Nicolas Chomont
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

5.  Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.

Authors:  Francesco Marras; Anna Casabianca; Federica Bozzano; Maria Libera Ascierto; Chiara Orlandi; Antonio Di Biagio; Emanuele Pontali; Chiara Dentone; Giancarlo Orofino; Laura Nicolini; Lucia Taramasso; Mauro Magnani; Francesco M Marincola; Ena Wang; Lorenzo Moretta; Andrea De Maria
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

6.  HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy.

Authors:  William R McManus; Michael J Bale; Jonathan Spindler; Ann Wiegand; Andrew Musick; Sean C Patro; Michele D Sobolewski; Victoria K Musick; Elizabeth M Anderson; Joshua C Cyktor; Elias K Halvas; Wei Shao; Daria Wells; Xiaolin Wu; Brandon F Keele; Jeffrey M Milush; Rebecca Hoh; John W Mellors; Stephen H Hughes; Steven G Deeks; John M Coffin; Mary F Kearney
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

7.  HIV persistence: clonal expansion of cells in the latent reservoir.

Authors:  Kyungyoon J Kwon; Robert F Siliciano
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

8.  Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

Authors:  Julio C C Lorenzi; Yehuda Z Cohen; Lillian B Cohn; Edward F Kreider; John P Barton; Gerald H Learn; Thiago Oliveira; Christy L Lavine; Joshua A Horwitz; Allison Settler; Mila Jankovic; Michael S Seaman; Arup K Chakraborty; Beatrice H Hahn; Marina Caskey; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

Review 9.  Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?

Authors:  Jennifer Totonchy; Ethel Cesarman
Journal:  Curr Opin Virol       Date:  2016-09-23       Impact factor: 7.090

Review 10.  Residual inflammation and viral reservoirs: alliance against an HIV cure.

Authors:  Marta Massanella; Rémi Fromentin; Nicolas Chomont
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.